Osaka: Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immune Globulin Infusion 10% (Human ... at level comparable to treatment with ...

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (fSCIG) Approved in Japan for Agammaglobulinemia ...

X-linked agammaglobulinemia (XLA) is an immune disorder that causes extremely ... a healthcare professional will administer immunoglobulin via an intravenous drip (through a vein) or subcutaneous ...

has shown a remarkable improvement following treatment with intravenous immunoglobulin (IVIG) therapy. After experiencing progressive tightness in his back and legs, the patient found it ...

A New York judge ruled that former President Donald Trump cannot claim presidential immunity to overturn his felony conviction. The decision from Judge Juan Merchan marks a temporary setback for ...

Children with newly diagnosed immune thrombocytopenia (ITP) treated with eltrombopag ... include corticosteroids, intravenous immunoglobulin (IVIg), and anti-D globulin; however, side effects ...